Study
AIMS LEAP Timepoint 1 (T1) and Timepoint 2 (T2)
ELU-4-4D20BB-1
The Longitudinal European Autism Project (LEAP) is currently the largest study in the world to identify variability in autism in terms of behaviour, cognition, co-occurring conditions, outcomes, brain structure/function and genetics. AIMS-LEAP participants have been followed up longitudinally over time, with the current dataset including Timepoint 1 and Timepoint 2 (approx. 12-24-months apart).
Types
Clinical Trial Ncit:c71104
Datasets
9- Longitudinal European Autism Project (LEAP) - DTI - Time point 1 & 2
- Longitudinal European Autism Project (LEAP) - Resting-state fMRI - Timepoint 1 (and 2)
- Longitudinal European Autism Project (LEAP) - Task based fMRI - Timepoint 1 (and 2)
- Longitudinal European Autism Project (LEAP) - Genetics
- Longitudinal European Autism Project (LEAP) - Structural MRI - Time point 1
- Longitudinal European Autism Project (LEAP) - Clinical - Time point 1 & 2
- Longitudinal European Autism Project (LEAP) - Cognitive - Time point 1 & 2
- Longitudinal European Autism Project (LEAP) - Eyes Tracking - Time point 1 & 2
- Longitudinal European Autism Project (LEAP) - EEG- Time point 1 & 2
Study description
- Primary purpose
- Autism Innovative Medicines Studies - Longitudinal European Autism Project (AIMS - LEAP)
- Study types
-
Clinical trial NCIT C71104
- Description of cohorts
- 437 autistic individuals and 300 non-autistic individuals total. Please note that N for individual datasets available here will be lower, and will differ between data modalities, due to participant consent preferences for external sharing and data quality. Total number 734 can vary depending on the study measure and timepoint, as well as participant consent preferences for external data sharing
Subjects
- Organisms
- Homo sapiens
- Number of subjects
- 737
- Sample sources
- Clinical Cognitive Neuroimaging Eye-tracking Data derived from blood and saliva samples
- Samples collected
- Cognitive Diffusion Tensor Imaging Psychometrics Electroencephalography Whole blood EDTA Whole blood tempus Physiological Resting state functional magnetic resonance imaging Blood plasma Task based functional magnetic resonance imaging Questionnaires Structural magnetic resonance imaging Eye tracking Interviews Saliva
Demographic and participant information
- Cohort characteristics
-
age at enrollment 6-35 yearCondition Autism , Intellectual disability , ADHD (co-occurring)